370
Participants
Start Date
March 16, 2021
Primary Completion Date
July 6, 2022
Study Completion Date
July 6, 2022
APP13007, 0.05%
APP13007 eye drop, 0.05%
Matching Vehicle Placebo for APP13007, 0.05%
Matching vehicle placebo eye drop
Alterman, Modi and Wolter, Poughkeepsie
Eye Care Specialists, Kingston
Carolina Cataract and Laser Center, Ladson
Clayton Eye Clinical Research LLC, Morrow
Dixon Eye Care, Albany
Levenson Eye Associates, Jacksonville
Rand Eye Institute, Deerfield Beach
International Research Center, Tampa
Eye Associates for Fort Myers, Fort Myers
The Eye Care Center, Louisville
Cincinnati Eye Institute, Cincinnati
Fraser Eye Center, Fraser
Black Hills Regional Eye Institute, Rapid City
Chicago Cornea Consultants, Hoffman Estates
Ophthalmology Associates, St Louis
Stiles Eyecare Excellence and Glaucoma Institute, PA, Overland Park
Houston Eye Associates, Houston
DCT-Shah Research Institute LLC dba Discovery Clinical Trials, Mission
Round Rock Eye Consultants, Round Rock
Cornea and Cataract Consultants of Arizona, Phoenix
Arizona Eye Center, Chandler
Carrot Eye Center, Mesa
Wellish Vision Institute, Las Vegas
Premiere Practice Management, LLC, Los Angeles
Wolstan and Goldberg Eye Associates, Torrance
LoBue Laser and Eye Medical Center Inc, Murrieta
Visionary Research Institute, Newport Beach
Michael K. Tran, MD, Inc., Westminster
Orange County Ophthalmology Medical Group, Garden Grove
North Bay Eye Associates, Petaluma
Metropolitan Eye Research and Surgery Institute, Palisades Park
Lead Sponsor
Formosa Pharmaceuticals, Inc.
INDUSTRY